SCHEMBL4199089

SCHEMBL4199089

C[N]C(C)c1ccccc1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.60
GABRB2 P47870 2/20 0.60
TSHR P16473 4/20 0.54
POLB P06746 3/20 0.43
LMNA P02545 4/20 0.39
HPGD P15428 3/20 0.39
CA2 P00918 3/20 0.39
CYP3A4 P08684 3/20 0.39
HIF1A Q16665 3/20 0.39
BLM P54132 2/20 0.39
CA1 P00915 2/20 0.39
CYP1A2 P05177 2/20 0.39
FAAH O00519 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
PTGS1 P23219 1/20 0.39
SLC6A2 P23975 1/20 0.39
HTR2C P28335 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5820809 0.76 GABRA1 (0.65) GABRA1GABRB2TSHRPOLBLMNA
SCHEMBL51565 0.75 GABRA1 (0.71) GABRA1GABRB2TSHRPOLBLMNA
SCHEMBL29440398 0.75 GABRA1 (0.71) GABRA1GABRB2TSHRPOLBLMNA
SCHEMBL15485453 0.75 GABRA1 (1.00) GABRA1GABRB2TSHRPOLBLMNA
SCHEMBL43297 0.75 GABRA1 (1.00) GABRA1GABRB2TSHRPOLBLMNA
SCHEMBL11597764 0.75 GABRA1 (0.71) GABRA1GABRB2TSHRPOLBLMNA
SCHEMBL29531559 0.75 GABRA1 (1.00) GABRA1GABRB2TSHRPOLBLMNA
SCHEMBL5357565 0.75 MIF (0.55) GABRA1GABRB2TSHRPOLBLMNA
SCHEMBL22444496 0.75 GABRA1 (0.52) GABRA1GABRB2TSHRPOLBLMNA
SCHEMBL2402247 0.74 ESR1 (0.48) GABRA1GABRB2TSHRCA2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1796675-A4 COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISEASES MERCK & CO INC (US) 2009-03-04 EP disclosed
EP-1796675-A2 COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISEASES Merck & Co., Inc. (US) 2007-06-20 EP disclosed
WO-2006039252-A2 COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISEASES MERCK & CO., INC. (US) 2006-04-13 WO disclosed
EP-0807109-A1 SUBSTITUTED 1,4-PIPERAZINE-HETEROARYL DERIVATIVES AS 5-HT 1D? RECEPTOR AGONISTS MERCK SHARP & DOHME LTD. (GB) 1997-11-19 EP disclosed
EP-0804434-A1 AZETIDINE, PYRROLIDINE AND PIPERIDINE DERIVATIVES MERCK SHARP & DOHME LTD. (GB) 1997-11-05 EP disclosed
EP-0796258-A1 AZETIDINE, PYRROLIDINE AND PIPERIDINE DERIVATIVES AS 5HT1 RECEPTOR AGONISTS MERCK SHARP & DOHME LTD. (GB) 1997-09-24 EP disclosed
WO-1996023785-A1 SUBSTITUTED 1,4-PIPERAZINE-HETEROARYL DERIVATIVES AS 5-HT1D RECEPTOR AGONISTS MERCK SHARP & DOHME LIMITED (GB) 1996-08-08 WO disclosed
WO-1996017842-A1 AZETIDINE, PYRROLIDINE AND PIPERIDINE DERIVATIVES AS 5HT1 RECEPTOR AGONISTS MERCK SHARP & DOHME LIMITED (GB) 1996-06-13 WO disclosed
WO-1996004274-A1 AZETIDINE, PYRROLIDINE AND PIPERIDINE DERIVATIVES MERCK SHARP & DOHME LIMITED (GB) 1996-02-15 WO disclosed